Skip to main content

Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions.

Boncler M, Rywaniak J, Sicinska P, Watala C

Publication: Blood Coagul Fibrinolysis (2011) • Vol 22 • Page 301-9PMID: 21372690View on PubMed

Purpose

The purpose of this paper was to determine the ability of modified C-reactive protein (mCRP) to modulate platelet function in different blood components.

Conclusion

mCRP was more effective at stimulating platelet activation in isolated platelets rather than whole blood. mCRP increased platelet adhesion to fibrinogen in isolated platelets but not in platelet rich plasma. Lastly, mCRP increased platelet aggregation in whole blood but not in undiluted platelet rich plasma.

Studies (1)

Purpose

The purpose of this study was to determine the ability of mCRP to modulate platelet function in different blood components.

Summary of Findings

Platelet activation was increased in whole blood with the addition of 100 ug/mL mCRP and in isolated platelets with the addition of 2, 20, or 100 ug/mL mCRP. No differences were seen between TRAP-activated platelet aggregation in whole blood or in isolated platelets. The percentage of platelet microparticles increased from 14.6% to 23.6% (p<0.005) in isolated platelets with the addition of 100 ug/mL mCRP, but no significant changes were noted when whole blood was analyzed. The addition of mCRP had no significant effect on ADP-induced platelet adhesion to fibrinogen in platelet rich plasma, but ADP-induced platelet adhesion to fibrinogen was approximately doubled for gel isolated platelets with concentrations of 20 and 100 ug/mL mCRP and was seven-fold higher than adhesion in platelet rich plasma (p<0.005). For whole blood, maximal platelet aggregation was significantly increased when 100 ug/mL mCRP was added, or with the strong platelet agonist collagen. mCRP had no effect on platelet aggregation in platelet rich plasma (undiluted), and the authors report this was true in the presence or absence of leukocytes. Dilution of platelet rich plasma (1:1 or 1:2) with saline or platelet poor plasma resulted in a heterogeneous response to mCRP- and collagen-stimulated platelet aggregation. But overall, when platelet rich plasma was diluted with saline as opposed to platelet poor plasma, platelet aggregation was significantly higher in response to both 100 ug/mL mCRP and collagen.

  • Biospecimens

    FluidBlood
    FluidPlasma
    CellWhite Cells
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Not specified
  • Platforms

    Cell count/volumeFlow cytometry
    Cell count/volumeHematology/ auto analyzer
    Cell count/volumePhotometer
    Cell count/volumeColorimetric assay
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    1:1 dilution
    1:2 dilution
    Platelet rich plasma diluted with platelet poor plasma
    Platelet rich plasma diluted with saline
    Biospecimen Aliquots and ComponentsBlood and blood products
    Leukocyte
    Platelet-poor plasma
    Platelet-rich plasma
    Platelets
    Whole blood
    Hematology/ auto analyzer SpecificReaction solution
    1 ug/mL collagen
    100 ug/mL mCRP
    2 ug/mL mCRP
    20 ug/mL mCRP
    Flow cytometry SpecificReaction solution
    100 ug/mL mCRP
    2 ug/mL mCRP
    20 ug/mL mCRP
    4 umol/L TRAP